Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin

Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin

Anja Schweizer,1 James E Foley,2 Wolfgang Kothny,2 Bo Ahrén31Novartis Pharma AG, Basel, Switzerland; 2Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA; 3Department of Clinical Sciences, Lund University, Lund, SwedenAbstract: Due to the progressive nature of type 2 diabetes,...

Full description

Bibliographic Details
Main Authors: Schweizer A, Foley JE, Kothny W, Ahrén B
Format: Article
Language:English
Published: Dove Medical Press 2013-02-01
Series:Vascular Health and Risk Management
Online Access:http://www.dovepress.com/clinical-evidence-and-mechanistic-basis-for-vildagliptin39s-effect-in--a12220

Internet

http://www.dovepress.com/clinical-evidence-and-mechanistic-basis-for-vildagliptin39s-effect-in--a12220

Similar Items